Cardio Diagnostics Holdings Inc. Common stock (CDIO) Stock Price

CDIOStock

$1.69−60.97%52W

Market Cap$5.00M

P/E—

PEG Ratio—

Div yield—

Beta2.32

CDIO Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-21.88%

Price vs S&P 500 (4W)-10.65%

VGM Score37.57

Book Value / Share (Quarterly)$2.51

P/TBV (Annual)0.81x

Indicated Dividend (Annual)$0.00

Cash Flow / Share (Quarterly)$-2.06

Price vs S&P 500 (YTD)-49.56%

Net Profit Margin (TTM)-44740.94%

EPS (TTM)$-2.92

10-Day Avg Trading Volume0.03M

EPS Excl Extra (TTM)$-2.92

EPS (Annual)$-3.71

ROI (Annual)-89.71%

Cash / Share (Quarterly)$1.89

Revenue Growth QoQ (YoY)-28.34%

ROA (Last FY)-83.67%

Revenue Growth TTM (YoY)-25.88%

EBITD / Share (TTM)$-2.74

ROE (5Y Avg)-126.08%

Operating Margin (TTM)-44659.75%

Cash Flow / Share (Annual)$-3.37

P/B Ratio0.67x

P/B Ratio (Quarterly)0.87x

Net Income / Employee (Annual)$-433,200

EV / Revenue (TTM)-35.80x

Net Interest Coverage (TTM)-460.19x

ROA (TTM)-76.02%

EPS Incl Extra (Annual)$-3.71

Current Ratio (Annual)9.79x

Quick Ratio (Quarterly)15.56x

3-Month Avg Trading Volume0.05M

52-Week Price Return-60.97%

Revenue / Employee (TTM)$1,000

Tangible BV / Share (Quarterly)$2.18

P/S Ratio (Annual)337.26x

Asset Turnover (Annual)0.00x

52-Week High$7.91

EPS Excl Extra (Annual)$-3.71

CapEx CAGR (5Y)69.47%

26-Week Price Return-11.98%

Quick Ratio (Annual)8.46x

13-Week Price Return-1.74%

Total Debt / Equity (Annual)0.04x

Current Ratio (Quarterly)17.15x

Enterprise Value$-517,700

Asset Turnover (TTM)0.00x

Revenue / Employee (Annual)$1,000

Pretax Margin (Annual)-43817.73%

Cash / Share (Annual)$2.80

3-Month Return Std Dev71.06%

Net Income / Employee (TTM)$-431,300

ROE (Last FY)-93.19%

Net Interest Coverage (Annual)-551.01x

EPS Basic Excl Extra (Annual)$-3.71

Receivables Turnover (TTM)1.72x

Total Debt / Equity (Quarterly)0.01x

EPS Incl Extra (TTM)$-2.92

Receivables Turnover (Annual)1.11x

ROI (TTM)-80.97%

P/S Ratio (TTM)345.89x

Revenue / Share (Annual)$0.01

Tangible BV / Share (Annual)$3.34

Price vs S&P 500 (52W)-76.50%

Year-to-Date Return-37.64%

5-Day Price Return-5.06%

EPS Normalized (Annual)$-3.71

ROA (5Y Avg)-96.26%

Net Profit Margin (Annual)-43817.73%

Month-to-Date Return-11.05%

EBITD / Share (Annual)$-3.66

Operating Margin (Annual)-43722.66%

ROI (5Y Avg)-114.91%

EPS Basic Excl Extra (TTM)$-2.92

P/TBV (Quarterly)1.00x

P/B Ratio (Annual)0.71x

Pretax Margin (TTM)-44740.94%

Book Value / Share (Annual)$3.82

Price vs S&P 500 (13W)-4.43%

Beta2.32x

Revenue / Share (TTM)$0.00

ROE (TTM)-82.27%

52-Week Low$0.97

gGradeD

mGradeC

vgmGradeD

CDIO Earnings Surprise History

Quarter	Report date	EPS estimate	EPS actual	Surprise
Q1 2025	May 15, 2025	-$1.80	-$0.97	+46.11%(+$0.83)
Q4 2024	Mar 20, 2025	-$1.80	-$0.30	+83.33%(+$1.50)
Q3 2024	Nov 13, 2024	-$1.50	-$1.80	-20.00%(-$0.30)
Q2 2024	Aug 12, 2024	-$2.70	-$1.80	+33.33%(+$0.90)

CDIO Analyst Recommendations

Jun 2025

Jul 2025

Aug 2025

Oct 2025

4.14

Industry Peers — In Vitro Diagnostics(18)

Symbol	Value Score	Growth Score	Momentum Score	P/S Ratio (TTM)	Revenue Growth TTM (YoY)	Gross Margin (TTM)	EPS Growth (5Y)	Price
CDIOCardio Diagnostics Holdings Inc. Common stock	—	D	C	345.9x	-25.9%	—	—	$1.69
IDXXIdexx Laboratories Inc	D	B	B	9.7x	12.8%	62.5%	14.3%	$560.36
LNTHLantheus Holdings, Inc	C	B	B	4.2x	2.4%	61.0%	40.7%	$99.70
NEOGNeogen Corp	C	C	A	2.9x	-0.3%	47.4%	—	$11.81
CLDXCelldex Therapeutics, Inc	F	F	C	13683.0x	-97.3%	17.6%	—	$27.53
NTLAIntellia Therapeutics, Inc	D	D	C	26.9x	12.6%	—	—	$11.42
QDELQuidelOrtho Corporation Common Stock	C	C	C	0.3x	-2.5%	44.6%	—	$12.91
ACHVAchieve Life Sciences, Inc.	F	F	B	36.8x	-89.3%	—	—	$6.38
MYGNMyriad Genetics Inc	C	C	D	0.5x	-3.2%	68.8%	—	$3.98
TKNOAlpha Teknova, Inc. Common Stock	D	C	B	8.7x	12.3%	34.6%	—	$7.08
NNNNAnbio Biotechnology Class A Ordinary Shares	F	C	F	34.0x	-5.7%	89.0%	—	$3.13
IMDXInsight Molecular Diagnostics Inc. Common Stock	F	D	C	59.0x	-60.8%	48.3%	—	$3.01
ICCCImmucell Corp	C	C	A	3.2x	8.5%	40.3%	—	$10.75
BMRABIOMERICA INC	B	D	B	1.9x	-16.2%	8.1%	—	$1.85
TRIBTrinity Biotech plc	B	D	C	0.1x	-16.6%	32.9%	—	$8.03
VNRXVolitionRx Limited	B	B	F	2.0x	86.3%	—	—	$0.18
QCLSQ/C Technologies, Inc. Common Stock	B	—	F	5.3x	—	24.7%	—	$0.54
VRAXVirax Biolabs Group Limited Ordinary Shares	—	B	F	156.9x	96.4%	62.0%	—	$1.45
CDIOWCardio Diagnostics Holdings Inc. Warrant	—	—	F	—	—	—	—	$0.01

About Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc develops AI-powered epigenetics-based clinical tests for coronary heart disease risk assessment, detection, and management. The company's diagnostic platform combines epigenetic and genetic biomarkers to provide personalized clinical insights for healthcare providers. Its three main solutions—Epi+Gen CHD, PrecisionCHD, and Actionable Clinical Intelligence—enable better identification and management of patients at risk for coronary events.